Israeli generic drug giant Teva will pay $519 million to settle charges that it paid bribes to foreign officials to win business in Russia, Ukraine and Mexico, US officials announced Thursday.
Dec 22, 2016
0
0
Six generic drug-makers artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication, 20 state attorneys general, led by Connecticut, said in a federal lawsuit filed Thursday.
Dec 15, 2016
0
0
Although generic oncology drugs can reduce patient costs and improve treatment access, the safety of these drugs in developing countries is uncertain, according to an international research team led by Dr. Charles Bennett, ...
Nov 2, 2016
0
8
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen's pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders.
Aug 30, 2016
0
1
The rising price for EpiPens, a drug delivery system that is crucial for persons experiencing potentially life-threatening allergic reactions, has resulted in outrage. The price increase, from about US$94 for a two-pack of ...
Aug 25, 2016
0
1
(HealthDay)—The first generic version of the flu medication Tamiflu has been approved by the U.S. Food and Drug Administration.
Aug 8, 2016
0
1
This week, I addressed questions from readers about generic drug prices as well as health plans with high deductibles and those that have grandfathered status under the health law.
Aug 1, 2016
0
2
In a new analysis published in the May issue of Health Affairs, Aaron Kesselheim, MD, JD, MPH, associate professor of medicine and director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology ...
May 2, 2016
0
1
U.S. spending on prescription drugs rose 8.5 percent last year, slightly less than in 2014, driven mainly by growing use of ultra-expensive new drugs and price hikes on other medicines.
Apr 14, 2016
0
3
